Empresa Zenyatta Ventures Ltd Toronto S.E.
Acciones
CA98943A1012
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Nano-graphite and Graphene Materials
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Ventas por región
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gregory Fenton
CEO | Chief Executive Officer | - | 11/07/18 |
Wendy Ford
DFI | Director of Finance/CFO | - | 16/05/22 |
Adam MacIntosh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 04/02/20 | |
Francis Dubé
BRD | Director/Board Member | - | 11/05/18 |
Nick Hansford
PRN | Corporate Officer/Principal | - | 01/01/21 |
Ryan Shacklock
PRN | Corporate Officer/Principal | - | - |
Monique Manaigre
LAW | General Counsel | - | 01/05/18 |
James Jordan
PRN | Corporate Officer/Principal | - | 01/07/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ilse Treurnicht
BRD | Director/Board Member | - | 05/07/22 |
John Snisarenko
BRD | Director/Board Member | 61 | 05/10/23 |
Francis Dubé
BRD | Director/Board Member | - | 11/05/18 |
Eric Wallman
CHM | Chairman | - | 11/05/18 |
Gregory Fenton
CEO | Chief Executive Officer | - | 11/07/18 |
Lisa Sim
BRD | Director/Board Member | - | 01/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 100 819 577 | 94 840 283 ( 94,07 %) | 0 | 94,07 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,77 % | 49,46 mil M | |
+1,00 % | 42,58 mil M | |
+50,47 % | 42,49 mil M | |
-5,26 % | 29,09 mil M | |
+13,68 % | 26,61 mil M | |
-22,99 % | 18,64 mil M | |
+8,22 % | 13,16 mil M | |
+32,41 % | 12,55 mil M | |
-1,62 % | 11,98 mil M |